Selected article for: "binding site and cov entry"

Author: Li, Wenhui; Sui, Jianhua; Huang, I-Chueh; Kuhn, Jens H.; Radoshitzky, Sheli R.; Marasco, Wayne A.; Choe, Hyeryun; Farzan, Michael
Title: The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
  • Cord-id: p4kuno89
  • Document date: 2007_10_1
  • ID: p4kuno89
    Snippet: The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group II coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 r
    Document: The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group II coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by β-strands 4 and 5.

    Search related documents:
    Co phrase search for related documents
    • accession number and luciferase reporter: 1
    • acute sars cov respiratory syndrome coronavirus and long terminal: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and long terminal repeat: 1
    • acute sars cov respiratory syndrome coronavirus and low affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars cov respiratory syndrome coronavirus and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute sars cov respiratory syndrome coronavirus and luciferase reporter: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute sars cov respiratory syndrome coronavirus and luciferase reporter gene: 1, 2, 3, 4, 5, 6
    • long terminal and low affinity: 1
    • long terminal and luciferase activity: 1
    • long terminal repeat and luciferase activity: 1
    • long terminal repeat control and luciferase activity: 1
    • low affinity and luciferase reporter: 1
    • luciferase activity and luminometer lb: 1, 2, 3
    • luciferase activity measure and luminometer lb: 1